-
Sunscreen Is Just the StartExperts say protection against UV rays and watching for changes in your skin are important tools in skin cancer risk prevention.
by Kyle Bagenstose
-
Ovarian Cancer: A Quest to Extend RemissionsNew treatments aim to lengthen remissions and push back recurrences.
by Erin O’Donnell
-
Survivor Profile
Educator and AdvocateFormer teacher Peggy Zuckerman helps others by sharing her experiences with stage IV kidney cancer.
by Kristin Baird Rattini
-
ADCs Make Their MarkAntibody-drug conjugates link a targeted medication with a toxic drug to deliver a potent payload inside cancer cells.
by Kendall K. Morgan
-
Forward Look
Bispecific Antibodies to Treat CancerHematologist-oncologist Saad Usmani talks about recent approvals for bispecific antibodies to treat multiple myeloma and other blood cancers.
by Ashley P. Taylor
-
Forward Look
New Hormonal Therapy Pill for Advanced Breast CancerNew oral hormonal therapy offers alternative to injections for some women with metastatic disease.
by Kris Conner
-
Forward Look
Tumor-infiltrating LymphocytesAdoptive T-cell therapy shows promise in treating metastatic melanoma.
by Marci A. Landsmann
-
Forward Look
Pausing Treatment for PregnancyYoung women who have had hormone receptor-positive breast cancer can safely suspend endocrine therapy to try to have a child.
by Carolyn Bernhardt
-
Sex and Gender Minorities Face Disparities in Breast Cancer CareLesbians, bisexual women and transgender men had a longer wait for diagnosis and a higher risk of recurrence.
by Jon Kelvey
-
More Prostate Cancer Patients Choose SurveillanceMen are increasingly opting to put off treatment for low-risk prostate cancer, and doctors say it’s a good thing.
by Kyle Bagenstose
Cancer patients say they want to be asked about their financial needs on a regular basis.
by Pamela Appea
Let Me Tell You a Story About the Power of Medical ResearchTen-year-old Michael Methner told his story about being diagnosed with optic nerve glioma at the AACR’s Rally for Medical Research.
by Cancer Research Catalyst
Aggressive Approach to Very Advanced Cancer Does Not Extend SurvivalStudy shows no benefit from treatment for cancers at very advanced stages of progression. Researchers urge end-of-life planning for these patients.
by Kyle Bagenstose
The Affordable Care Act’s Impact on Access to Cancer CareA study at the AACR Cancer Health Disparities Conference found more people got quality cancer care after the ACA went into effect.
by Cancer Research Catalyst
-
AACR Grant Propels Progress in Immunotherapy ResearchA grant from the American Association for Cancer Research (AACR) helped Marco Ruella, MD, develop a new approach to immunotherapy.
-
Self-screening for Cancer: Home Sweet HomeNew cervical cancer self-screening options and a portable blood test device could lead to changes in at-home cancer screening.
Alexis Browning
